IP Library Granted Patent US 8,433,605
Granted Patent B2
US 8,433,605 · App. 13/399,150 · Granted Apr 30, 2013

System for clinical trial subject compliance

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,433,605
App. No.
13/399,150
Granted
Apr 30, 2013
Kind
B2
Abstract

The present invention is designed to develop research protocols for clinical trials. The invention also can track and enhance subject compliance with a research protocol. The invention further provides evaluability data related to subject performance in the clinical trial. According to an alternative embodiment of the invention, a portable electronic device is used to query and collect data from the subject.

Claims (69)

1. A method for classifying results from one or more participants in a clinical trial, the method comprising:

a. electronically accessing evaluability data obtained during the clinical trial, wherein the evaluability data is from the one or more participants in the clinical trial, wherein the evaluability data is stored on an electronic device, wherein the evaluability data comprise data from one or more evaluability data categories;

b. comparing the evaluability data from the one or more evaluability data categories to a norm to classify clinical trial results from each of the one or more participants in the clinical trial based on a type of compliance; and

c. analyzing the classified clinical trial results from the one or more participants with a similar type of compliance.

2. The method of claim 1 , wherein the type of compliance comprises good compliance, non-compliance, or minor non-compliance.

3. The method of claim 1 , wherein the one or more evaluability data categories are used to determine a desirability of retaining the one or more participants in the clinical trial or incorporating the evaluability data from the one or more participants in the clinical trial results.

4. The method of claim 1 , wherein the comparing comprises a quantitative analysis.

5. The method of claim 4 , wherein the quantitative analysis comprises a statistical or data mining technique.

6. The method of claim 5 , wherein the statistical or data mining technique comprises logistic regression, discriminant function analysis, classification and regression trees, neural networks, or multiple linear regression.

7. The method of claim 1 , wherein the one or more evaluability data categories comprise timeliness of data entry and another category.

8. The method of claim 7 , wherein the another category comprises consistency with other collected data, proximity of the data to an expected data range, or completeness of the data.

9. The method of claim 1 , wherein the comparing the evaluability data occurs during the clinical trial.

10. The method of claim 1 , further comprising generating at least one compliance enhancing feature.

11. The method of claim 10 , wherein the at least one compliance enhancing feature comprises a question to be posed to a user to determine a reason for non-compliance, an alarm tone, or a delay in reporting.

12. The method of claim 1 , wherein the norm is a historic norm.

13. The method of claim 1 , wherein the norm is a population norm.

14. The method of claim 1 , further comprising gathering the evaluability data in an evaluability database.

15. The method of claim 14 , wherein the evaluability database is a disease-specific database.

16. The method of claim 14 , wherein the evaluability database is a population-specific database.

17. The method of claim 14 , wherein the evaluability database is adapted to store data related to subject compliance.

18. The method of claim 1 , wherein the electronic device is a workstation.

19. The method of claim 1 , wherein the electronic device is a handheld electronic device.

20. The method of claim 19 , wherein the handheld electronic device is a handheld portable computer or phone.

21. The method of claim 1 , wherein the electronic device is connected to the Internet.

22. A computer readable medium having stored thereon sequences of instructions, which, when executed by a computer system, cause the computer system to perform:

a. electronically accessing evaluability data obtained during a clinical trial, wherein the evaluability data is from one or more participants in the clinical trial, wherein the evaluability data is stored on an electronic device, wherein the evaluability data comprise data from one or more evaluability data categories;

b. comparing the evaluability data from the one or more evaluability data categories to a norm to classify clinical trial results from the one or more participants in the clinical trial based on a type of compliance; and

c. analyzing the classified clinical trial results from the one or more participants with a similar type of compliance.

23. The computer readable medium of claim 22 , wherein the type of compliance comprises good compliance, non-compliance, or minor non-compliance.

24. The computer readable medium of claim 22 , wherein the one or more evaluability data categories are used to determine a desirability of retaining the one or more participants in the trial or incorporating the evaluability data from the one or more participants in the trial results.

25. The computer readable medium of claim 22 , wherein the comparing comprises a quantitative analysis.

26. The computer readable medium of claim 25 , wherein the quantitative analysis comprises a statistical or data mining technique.

27. The computer readable medium of claim 26 , wherein the statistical or data mining technique comprises logistic regression, discriminant function analysis, classification and regression trees, neural networks, or multiple linear regression.

28. The computer readable medium of claim 22 , wherein the one or more evaluability data categories comprise timeliness of data entry and another category.

29. The computer readable medium of claim 28 , wherein the another category comprises consistency with other collected data, proximity of the data to an expected data range, or completeness of the data.

30. The computer readable medium of claim 22 , wherein the comparing the evaluability data occurs during the clinical trial.

31. The computer readable medium of claim 22 , further comprising generating at least one compliance enhancing feature.

32. The computer readable medium of claim 31 , wherein the at least one compliance enhancing feature comprises a question to be posed to a user to determine a reason for non-compliance, an alarm tone, or a delay in reporting.

33. The computer readable medium of claim 22 , wherein the norm is a historic norm.

34. The computer readable medium of claim 22 , wherein the norm is a population norm.

35. The computer readable medium of claim 22 , further comprising gathering the evaluability data in an evaluability database.

36. The computer readable medium of claim 35 , wherein the evaluability database is a disease-specific database.

37. The computer readable medium of claim 35 , wherein the evaluability database is a population-specific database.

38. The computer readable medium of claim 35 , wherein the evaluability database is adapted to store data related to subject compliance.

39. The computer readable medium of claim 22 , wherein the electronic device is a workstation.

40. The computer readable medium of claim 22 , wherein the electronic device is a handheld electronic device.

41. The computer readable medium of claim 40 , wherein the handheld electronic device is a handheld portable computer or a phone.

42. The computer readable medium of claim 22 , wherein the electronic device is connected to the Internet.

43. A system comprising an electronic device for storing evaluability data obtained during a clinical trial, wherein the evaluability data is from one or more participants in the clinical trial, wherein the evaluability data comprise data from one or more evaluability data categories, wherein the electronic device can compare the evaluability data from the one or more participants in the clinical trial to a norm to classify clinical trial results from the one or more participants in the clinical trial based on a type of compliance, wherein the electronic device can analyze the classified clinical trial results from the one or more participants with a similar type of compliance.

44. The system of claim 43 , wherein the type of compliance comprises good compliance, non-compliance, or minor non-compliance.

45. The system of claim 43 , wherein the one or more evaluability data categories are used to determine a desirability of retaining the one or more participants in the trial or incorporating the evaluability data from the one or more participants in the trial results.

46. The system of claim 43 , wherein the comparing comprises a quantitative analysis.

47. The system of claim 46 , wherein the quantitative analysis comprises a statistical or data mining technique.

48. The system of claim 47 , wherein the statistical or data mining technique comprises logistic regression, discriminant function analysis, classification and regression trees, neural networks, or multiple linear regression.

49. The system of claim 43 , wherein the one or more evaluability data categories comprise timeliness of data entry and another category.

50. The system of claim 49 , wherein the another category comprises consistency with other collected data, proximity of the data to an expected data range, or completeness of the data.

51. The system of claim 43 , wherein the comparing the evaluability data occurs during the clinical trial.

52. The system of claim 43 , further comprising generating at least one compliance enhancing feature.

53. The system of claim 52 , wherein the at least one compliance enhancing feature comprises a question to be posed to a user to determine a reason for non-compliance, an alarm tone, or a delay in reporting.

54. The system of claim 43 , wherein the norm is a historic norm.

55. The system of claim 43 , wherein the norm is a population norm.

56. The system of claim 43 , further comprising gathering the evaluability data in an evaluability database.

57. The system of claim 56 , wherein the evaluability database is a disease-specific database.

58. The system of claim 56 , wherein the evaluability database is a population-specific database.

59. The system of claim 56 , wherein the evaluability database is adapted to store data related to subject compliance.

60. The system of claim 43 , wherein the electronic device is a workstation.

61. The system of claim 43 , wherein the electronic device is a handheld electronic device.

62. The system of claim 61 , wherein the handheld electronic device is a handheld portable computer or a phone.

63. The system of claim 43 , wherein the electronic device is connected to the Internet.

Assignments (13)
RELEASE OF SECURITY INTEREST AT REEL/FRAME 051837/0001 Recorded Jan 17, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: ERESEARCHTECHNOLOGY, INC.; BIOMEDICAL SYSTEMS LLC (F/K/A BIOMEDICAL SYSTEMS CORPORATION)
Reel/Frame 069939/0303 →
RELEASE OF SECURITY INTEREST AT REEL/FRAME 051832/0777 Recorded Jan 17, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: ERESEARCHTECHNOLOGY, INC.; BIOMEDICAL SYSTEMS LLC (F/K/A BIOMEDICAL SYSTEMS CORPORATION)
Reel/Frame 069939/0212 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2020
From: NEWSTAR FINANCIAL, INC.
To: ERESEARCHTECHNOLOGY, INC.; PHT CORPORATION
Reel/Frame 051754/0838 →
SECOND LIEN SECURITY AGREEMENT Recorded Feb 6, 2020
From: BIOMEDICAL SYSTEMS LLC; ICARDIAC TECHNOLOGIES LLC; ERESEARCHTECHNOLOGY, INC.
To: GOLDMAN SACHS BANK USA
Reel/Frame 051837/0001 →
FIRST LIEN SECURITY AGREEMENT Recorded Feb 5, 2020
From: BIOMEDICAL SYSTEMS LLC; ICARDIAC TECHNOLOGIES LLC; ERESEARCHTECHNOLOGY, INC.
To: GOLDMAN SACHS BANK USA
Reel/Frame 051832/0777 →
RELEASE OF SECURITY INTEREST Recorded Feb 4, 2020
From: GOLDMAN SACHS BANK USA
To: ERESEARCH TECHNOLOGY, INC.; BIOMEDICAL SYSTEMS CORPORATION; ICARDIAC TECHNOLOGIES, INC.
Reel/Frame 051717/0031 →
SECURITY INTEREST Recorded Jun 6, 2016
From: ERESEARCHTECHNOLOGY, INC.; PHT CORPORATION
To: NEWSTAR FINANCIAL, INC., AS COLLATERAL AGENT
Reel/Frame 038812/0804 →
SECURITY AGREEMENT Recorded May 2, 2016
From: ERESEARCHTECHNOLOGY, INC.; PHT CORPORATION
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 038591/0899 →
RELEASE OF PATENT SECURITY INTEREST AT REEL/FRAME NO. 29991/0268 Recorded May 8, 2015
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: COVANCE CARDIAC SAFETY SERVICES INC.; INVIVODATA, INC.; ERESEARCHTECHNOLOGY, INC.
Reel/Frame 035624/0891 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2014
From: INVIVODATA, INC.
To: ERESEARCHTECHNOLOGY, INC.
Reel/Frame 032274/0134 →
CHANGE OF ADDRESS Recorded Feb 21, 2014
From: INVIVODATA, INC.
To: INVIVODATA, INC.
Reel/Frame 032325/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2013
From: HUFFORD, MICHAEL R.; PETERSON, DAVID; PATY, JEAN A.; SHIFFMAN, SAUL
To: INVIVODATA, INC.
Reel/Frame 031605/0782 →
PATENT SECURITY AGREEMENT Recorded Mar 13, 2013
From: COVANCE CARDIAC SAFETY SERVICS INC.; INVIVODATA, INC.; ERESEARCHTECHNOLOGY, INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 029991/0268 →